In a prospective cohort study, Irwin and colleagues have found that elevated IL-8 was associated with lower severity of depressive symptoms, favorable treatment responses, and a decreased rate of new and recurrent major depression in breast cancer survivors [70]. This evidence concerns the gene CXCL8 and breast cancer.